Impact of comorbid borderline personality disorder on inpatient treatment for bulimia nervosa: analysis of routine data

Table 3 Results of the repeated measures analyses of variance for changes from admission to discharge in BDI-II, GSI, GAF, and BMI for inpatients with BN and BN + BPD

Variable	Effect	F (df), p	Partial η²
BDI-II	Treatment	418.94 (1, 672), < 0.001	0.38
	Diagnosis	70.59 (1, 672), < 0.001	0.10
	Treatment × Diagnosis	5.60 (1, 672), 0.018	0.01
GSI	Treatment	174.67 (1, 984), < 0.001	0.15
	Diagnosis	74.28 (1, 984), < 0.001	0.07
	Treatment × Diagnosis	2.76 (1, 984), 0.097	< 0.01
GAF	Treatment	228.35 (1, 365), < 0.001	0.39
	Diagnosis	8.55 (1, 365), 0.004	0.02
	Treatment × Diagnosis	0.75 (1, 365), 0.387	< 0.01
BMI	Treatment	72.15 (1, 721), < 0.001	0.09
	Diagnosis	2.56 (1, 721), 0.110	< 0.01
	Treatment × Diagnosis	7.50 (1, 721), 0.006	0.01

Note. df degrees of freedom, BDI-II Beck Depression Inventory II, GSI Global Severity Index, GAF Global Assessment of Functioning, BMI body mass index, BN bulimia nervosa, BN + BPD bulimia nervosa with comorbid Borderline Personality disorder

ISSN: 2051-6673